Hospira Inc. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Aug 22, 2025
  • 62 Class I recalls
  • Last warning letter 2017
Inspections 50 6 OAI
Recalls 257 62 Class I (24%)
Warning letters 3 Latest Feb 14, 2017
510(k) clearances 45 Latest Mar 28, 2017

Hospira Inc. has 257 FDA recalls (62 Class I), 50 inspections, 45 510(k) clearances and 3 compliance actions on record. FDA has issued 3 warning letters to Hospira Inc., the most recent on Feb 14, 2017. FDA has published 9 Form 483s for Hospira Inc..

What these totals cover: FDA records filed under the name "Hospira Inc." and its spelling variant "Hospira". They do not include records filed under Pfizer or other names in its corporate family; those are listed under Related names, each with its own counts.

Latest recall
D-0052-2027 · Sep 29, 2026 · filed under Pfizer
Latest recall under this name
D-0862-2017 · Class I · Apr 21, 2017
Latest inspection
Aug 22, 2025 · NAI
Latest 510(k)
Mar 28, 2017

Newer recall under related name Pfizer: Sep 29, 2026, D-0052-2027.

Part of the Pfizer corporate family.

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls257 (62 Class I)Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026Current
510(k) clearances45Nov 22, 2026File dated Nov 18, 2026Current
Inspections50Nov 22, 2026Newest record Nov 9, 2026Current
Compliance actions3Nov 22, 2026Newest record Nov 13, 2026Current

FDA record by year

Hospira Inc.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Hospira Inc.: FDA inspections per year

2017: 1 inspection (0 OAI), 1 warning letter, 1 recall record (1 Class I) 2018: 2 inspections (1 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 2 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 2 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 3 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202530000
202420000
202300000
202200000
202100000
202020000
201910000
201821000
201710111

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Hospira Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Hospira Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Hospira Inc. FDA Warning Letters

3 warning letters from Aug 12, 2009 to Feb 14, 2017.

IssuedSubjectIssuing officeClose-out letter
Feb 14, 2017 · Record page
Mar 7, 2014 · Record page
Aug 12, 2009 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Hospira Inc. Form 483s

9 Form 483s published by FDA.

DateDocumentFEI
Mar 10, 2026 · Document on fda.gov 4831925262
Jan 18, 2020 · Document on fda.gov 4831925262
Jan 17, 2020 · Document on fda.gov 4831925262
Jul 11, 2015 · Document on fda.gov 4831021343
Jul 10, 2015 · Document on fda.gov 4831021343
Jul 10, 2015 · Document on fda.gov 4831048698
Jul 10, 2015 · Document on fda.gov 4831048698
Jul 10, 2015 · Document on fda.gov 4831628454
Oct 24, 2012 · Document on fda.gov 4831925262

A Form 483 lists the observations FDA investigators made at the end of an inspection. FDA publishes some Form 483s in its reading room, and each date links to that document. Read the observations with the FDA 483 search.

Recent recalls

257 recall records from Mar 16, 2011 to Apr 21, 2017. Showing the 20 most recent. View all 257 recall records

NumberClassProductDate
D-0862-2017Class IInfant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per…Apr 21, 2017
D-0153-2017Class IIFentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL, Rx only, Hospira…Nov 1, 2016
D-1500-2016Class IIDOBUTamine Injection, USP 250 mg/20 mL, 20 mL Vial, For IV Use Only, Must be Diluted Prior to Use…Aug 15, 2016
D-0169-2017Class III5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Single-dose ampule, 5 count box, Rx Only…Jun 29, 2016
D-1359-2016Class IIDiazepam Injection USP 10mg/2mL (5 mg/mL, 2 mL), Rx only, Hospira Inc. Lake Forest, IL 60045, NDC…Jun 23, 2016
D-1033-2016Class IIVancomycin Hydrochloride for Injection, USP, 10 g, 100 mL vial, Rx only, Hospira, Lake Forest, IL…May 6, 2016
Z-1832-2016Class IIThe Plum 360 is a large volume infuser capable of delivering fluids for a variety of therapies such…Mar 25, 2016
Z-1833-2016Class IIThe Plum A+ is a dual-line volumetric infusion system designed to meet the growing demand for…Mar 25, 2016
D-0854-2016Class IIIMagnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 mEq Magnesium/mL, 20 mL Single-dose vial…Mar 23, 2016
D-1137-2016Class IMagnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 mEq Magnesium/mL, 20 mL Single-dose vial…Mar 23, 2016
D-0865-2016Class I8.4% Sodium Bicarbonate Injection, USP 50mEq (1mEq/mL), 4.2 grams (84 mg/mL), 50 mL, Rx only…Mar 18, 2016
D-0836-2016Class IIIQuelicin (Succinylcholine Chloride) Injection, USP 200 mg. (20 mg/mL), 10 mL Multiple-dose vial…Mar 15, 2016
D-0831-2016Class IIMannitol I.V., 20%, USP (20 g/ 100 mL), Packaged in 250 mL Bags, Rx Only, Hospira, Inc., Lake…Mar 8, 2016
D-0828-2016Class IIDextrose Injection, USP, 50%, Packaged as 500 mL in 1000 mL Bag, Rx only, Hospira, Inc., Lake…Mar 8, 2016
D-0827-2016Class IIDextrose Injection, USP, 70%, Packaged as 500 mL in 1000 mL Bag, Rx only, Hospira, Inc., Lake…Mar 8, 2016
D-0832-2016Class IIPotassium Chloride Injection 20 mEq, 400 mEq/L, Packaged in 50 mL Bags, Rx only, Hospira, Inc., Lake…Mar 8, 2016
D-0830-2016Class IIAminosyn-PF (amino acids) 7%, Sulfite-Free, 500 mL Bags, Rx Only, Hospira, Inc., Lake Forest, IL…Mar 8, 2016
D-0829-2016Class IIDextrose Injection, USP, 20%, Packaged as 500 mL in 1000 mL Bags, Rx only, Hospira, Inc., Lake…Mar 8, 2016
D-0727-2016Class IIINormosol-M and 5% Dextrose (multiple electrolytes and 5% dextrose) Injection Type 1, USP, 1000 mL…Feb 2, 2016
D-0668-2016Class IMagnesium Sulfate in Water for Injection, (0.325 mEq Mg++/mL) 40 mg/mL, 2 g Total, 50 mL Single-Dose…Jan 5, 2016

Recent FDA inspections

50 inspections from Apr 9, 2009 to Aug 22, 2025. Showing the 20 most recent. View all 50 inspections

DateSiteProductClassificationFEI
Aug 22, 2025Lake Forest, ILDrugsNo Action Indicated (NAI)3004591926
Feb 7, 2025Rocky Mount, NCDrugsNo Action Indicated (NAI)1021343
Jan 17, 2025Mcpherson, KSDrugsVoluntary Action Indicated (VAI)1925262
Jun 7, 2024Lake Forest, ILBiologicsNo Action Indicated (NAI)3004591926
Mar 27, 2024Mcpherson, KSBiologicsNo Action Indicated (NAI)1925262
Feb 27, 2020Lake Forest, ILDrugsNo Action Indicated (NAI)3004591926
Jan 17, 2020Mcpherson, KSDrugsVoluntary Action Indicated (VAI)1925262
Nov 21, 2019Rocky Mount, NCDrugsVoluntary Action Indicated (VAI)1021343
Aug 15, 2018Mcpherson, KSDrugsOfficial Action Indicated (OAI)1925262
Feb 2, 2018Rocky Mount, NCDevicesVoluntary Action Indicated (VAI)1021343
Oct 27, 2017Mcpherson, KSVeterinaryVoluntary Action Indicated (VAI)1925262
Jun 8, 2016Mcpherson, KSDrugsOfficial Action Indicated (OAI)1925262
May 26, 2016Rocky Mount, NCDrugsNo Action Indicated (NAI)1021343
Nov 19, 2015Haina, San Cristobal, Dominican Republic (The)DevicesNo Action Indicated (NAI)3002806326
Sep 24, 2015Rocky Mount, NCDevicesVoluntary Action Indicated (VAI)1021343
Apr 13, 2015Lake Forest, ILDrugsVoluntary Action Indicated (VAI)3004591926
Apr 3, 2015Mcpherson, KSDrugsVoluntary Action Indicated (VAI)1925262
Dec 9, 2014Lake Forest, ILVeterinaryNo Action Indicated (NAI)3004591926
Jun 13, 2014Rocky Mount, NCVeterinaryNo Action Indicated (NAI)1021343
Apr 23, 2014Mcpherson, KSVeterinaryNo Action Indicated (NAI)1925262
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 3 compliance actions under Hospira Inc.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Feb 14, 2017.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

6 inspected sites, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3004591926Lake Forest, IL10Aug 22, 2025
FEI 1021343Rocky Mount, NC12Feb 7, 2025
FEI 1925262Mcpherson, KS17Jan 17, 2025
FEI 3002806326Haina, San Cristobal, Dominican Republic (The)3Nov 19, 2015
FEI 1048698Clayton, NC6Jun 13, 2013
FEI 2921482Morgan Hill, CA2Jul 28, 2010

Recent 510(k) clearances

45 510(k) clearances from Aug 24, 2004 to Mar 28, 2017. Showing the 20 most recent. View all 45 510(k) clearances

K-NumberDeviceDate
K161469Plum 360(TM) Infusion System with MedNet/ Smart Card Plug and Play ModuleMar 28, 2017
K161036Hospira Extension Set, Hospira Primary SetJan 6, 2017
K160492Hospira Sapphire SetsDec 6, 2016
K160870Hospira Administration SetsJun 1, 2016
K143612LifeCare PCA Infusion SystemApr 8, 2016
K143087Hospira Blood SetMar 4, 2015
K143015Hospira Primary SetsFeb 25, 2015
K141789PLUM 360 INFUSION SYSTEM WITH HOSPIRA MEDNET, SMART CARD PLUG N PLAY CE 3.0 MODULE FOR PLUM A+…Jan 16, 2015
K142622IV AdministrationJan 15, 2015
K142974Extension SetsJan 9, 2015
K142433Hospira Extension SetDec 8, 2014
K142367Hospira Primary SetsNov 25, 2014
K141102HOSPIRA MEDNET MEDICATION MANAGEMENT SUITEJul 8, 2014
K133602ADD-VANTAGE ADDAPTORJan 24, 2014
K132276STERILE EMPTY GLASS CONTAINER, 250ML, STERILE EMPTY GLASS CONTAINER, 500 ML, STERILE EMPTY GLASS…Nov 12, 2013
K121032PRIMARY SYMBIQ SET, DITAL MICROBORE TUBING, 0.2 MICRON FILTER, NON-DEHPJun 21, 2012
K110901SYMBIQ INFUSION AND ADMINSTRATION SETMar 5, 2012
K113683LIFESHIELD VISION INFUSION SET WITH PRE-PIERCED RESEALJan 12, 2012
K103224HOSPIRA PLUM INFUSION SET; HOSPIRA INFUSION SET WITH YELLOW STRIPE TUBINGJan 7, 2011
K103344INFUSION SETSDec 10, 2010

Hospira Inc. and the FDA: common questions

Has Hospira Inc. received an FDA warning letter?

Yes. FDA has issued 3 warning letters to Hospira Inc.. The most recent is dated Feb 14, 2017.

Has Hospira Inc. received an FDA Form 483?

FDA has published 9 Form 483s for Hospira Inc. in its reading room, the most recent dated Mar 10, 2026. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Hospira Inc.?

The most recent FDA inspection on file ended Aug 22, 2025 at Lake Forest, IL and was classified NAI. FDA has 50 inspections of Hospira Inc. on file, 6 of them classified OAI (official action indicated).

Has Hospira Inc. had an FDA recall?

Yes. Hospira Inc. has 257 FDA recalls on record, 62 of them Class I, the most serious class. The most recent under this name started Apr 21, 2017. A newer recall, dated Sep 29, 2026, is filed under the related name Pfizer.

Need more than this page shows? Ask about Hospira Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.